-
1
-
-
34247369329
-
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group
-
Adès, L., Chevret, S., Raffoux, E., de Botton, S., Guerci, A., Pigneux, A., Stoppa, A.M., Lamy, T., Rigal-Huguet, F., Vekhoff, A., Meyer-Monard, S., Maloisel, F., Deconinck, E., Ferrant, A., Thomas, X., Fegueux, N., Chomienne, C., Dombret, H., Degos, L. & Fenaux, P.; European Acute Promyelocytic Leukemia Group. (2006) Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. Journal of Clinical Oncology, 24, 5703-5710.
-
(2006)
Journal of Clinical Oncology
, vol.24
, pp. 5703-5710
-
-
Adès, L.1
Chevret, S.2
Raffoux, E.3
de Botton, S.4
Guerci, A.5
Pigneux, A.6
Stoppa, A.M.7
Lamy, T.8
Rigal-Huguet, F.9
Vekhoff, A.10
Meyer-Monard, S.11
Maloisel, F.12
Deconinck, E.13
Ferrant, A.14
Thomas, X.15
Fegueux, N.16
Chomienne, C.17
Dombret, H.18
Degos, L.19
Fenaux, P.20
more..
-
2
-
-
38949092914
-
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
-
Adès, L., Sanz, M.A., Chevret, S., Montesinos, P., Chevallier, P., Raffoux, E., Vellenga, E., Guerci, A., Pigneux, A., Huguet, F., Rayon, C., Stoppa, A.M., de la Serna, J., Cahn, J.Y., Meyer-Monard, S., Pabst, T., Thomas, X., de Botton, S., Parody, R., Bergua, J., Lamy, T., Vekhoff, A., Negri, S., Ifrah, N., Dombret, H., Ferrant, A., Bron, D., Degos, L. & Fenaux, P. (2008) Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood, 111, 1078-1084.
-
(2008)
Blood
, vol.111
, pp. 1078-1084
-
-
Adès, L.1
Sanz, M.A.2
Chevret, S.3
Montesinos, P.4
Chevallier, P.5
Raffoux, E.6
Vellenga, E.7
Guerci, A.8
Pigneux, A.9
Huguet, F.10
Rayon, C.11
Stoppa, A.M.12
de la Serna, J.13
Cahn, J.Y.14
Meyer-Monard, S.15
Pabst, T.16
Thomas, X.17
de Botton, S.18
Parody, R.19
Bergua, J.20
Lamy, T.21
Vekhoff, A.22
Negri, S.23
Ifrah, N.24
Dombret, H.25
Ferrant, A.26
Bron, D.27
Degos, L.28
Fenaux, P.29
more..
-
3
-
-
34347386848
-
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML/RARA transcript after consolidation therapy; the Japan Adult Leukemia Study Group (JALSG) APL97
-
Asou, N., Kishimoto, Y., Kiyoi, H., Okada, M., Kawai, Y., Tsuzuki, M., Horikawa, K., Matsuda, M., Shinagawa, K., Kobayashi, T., Ohtake, S., Nishimura, M., Takahashi, M., Yagasaki, F., Takeshita, A., Kimura, Y., Iwanaga, M., Naoe, T. & Ohno, R.; Japan Adult Leukemia Study Group. (2007) A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML/RARA transcript after consolidation therapy; the Japan Adult Leukemia Study Group (JALSG) APL97. Blood, 110, 59-66.
-
(2007)
Blood
, vol.110
, pp. 59-66
-
-
Asou, N.1
Kishimoto, Y.2
Kiyoi, H.3
Okada, M.4
Kawai, Y.5
Tsuzuki, M.6
Horikawa, K.7
Matsuda, M.8
Shinagawa, K.9
Kobayashi, T.10
Ohtake, S.11
Nishimura, M.12
Takahashi, M.13
Yagasaki, F.14
Takeshita, A.15
Kimura, Y.16
Iwanaga, M.17
Naoe, T.18
Ohno, R.19
-
4
-
-
0037902046
-
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
-
Au, W.Y., Kumana, C.R., Kou, M., Mak, R., Chan, G.C., Lam, C.W. & Kwong, Y.L. (2003) Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia. Blood, 102, 407-408.
-
(2003)
Blood
, vol.102
, pp. 407-408
-
-
Au, W.Y.1
Kumana, C.R.2
Kou, M.3
Mak, R.4
Chan, G.C.5
Lam, C.W.6
Kwong, Y.L.7
-
5
-
-
0025300248
-
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA
-
Avvisati, G., Mandelli, F., Petti, M.C., Vegna, M.L., Spadea, A., Liso, V., Specchia, G., Bernasconi, C., Alessandrino, E.P., Piatti, C. & Carella, A.M. (1990) Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA. European Journal of Haematology, 44, 257-260.
-
(1990)
European Journal of Haematology
, vol.44
, pp. 257-260
-
-
Avvisati, G.1
Mandelli, F.2
Petti, M.C.3
Vegna, M.L.4
Spadea, A.5
Liso, V.6
Specchia, G.7
Bernasconi, C.8
Alessandrino, E.P.9
Piatti, C.10
Carella, A.M.11
-
6
-
-
0029819203
-
AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) pilot study
-
Avvisati, G., Lo-Coco, F., Diverio, D., Falda, M., Ferrara, F., Lazzarino, M., Russo, D., Petti, M.C. & Mandelli, F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) pilot study. Blood, 88, 1390-1398.
-
(1996)
Blood
, vol.88
, pp. 1390-1398
-
-
Avvisati, G.1
Lo-Coco, F.2
Diverio, D.3
Falda, M.4
Ferrara, F.5
Lazzarino, M.6
Russo, D.7
Petti, M.C.8
Mandelli, F.9
-
7
-
-
79955991053
-
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
-
Avvisati, G., Lo-Coco, F., Paoloni, F.P., Petti, M.C., Diverio, D., Vignetti, M., Latagliata, R., Specchia, G., Baccarani, M., Di Bona, E., Fioritoni, G., Marmont, F., Rambaldi, A., Di Raimondo, F., Kropp, M.G., Pizzolo, G., Pogliani, E.M., Rossi, G., Cantore, N., Nobile, F., Gabbas, A., Ferrara, F., Fazi, P., Amadori, S. & Mandelli, F.; GIMEMA, AIEOP, and EORTC Cooperative Groups. (2011) AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood, 117, 4716-4725.
-
(2011)
Blood
, vol.117
, pp. 4716-4725
-
-
Avvisati, G.1
Lo-Coco, F.2
Paoloni, F.P.3
Petti, M.C.4
Diverio, D.5
Vignetti, M.6
Latagliata, R.7
Specchia, G.8
Baccarani, M.9
Di Bona, E.10
Fioritoni, G.11
Marmont, F.12
Rambaldi, A.13
Di Raimondo, F.14
Kropp, M.G.15
Pizzolo, G.16
Pogliani, E.M.17
Rossi, G.18
Cantore, N.19
Nobile, F.20
Gabbas, A.21
Ferrara, F.22
Fazi, P.23
Amadori, S.24
Mandelli, F.25
more..
-
8
-
-
0015605395
-
Acute promyelocytic leukemia: results of treatment by daunorubicin
-
Bernard, J., Weil, M., Boiron, M., Jacquillat, C., Flandrin, G. & Gemon, M.F. (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood, 41, 489-496.
-
(1973)
Blood
, vol.41
, pp. 489-496
-
-
Bernard, J.1
Weil, M.2
Boiron, M.3
Jacquillat, C.4
Flandrin, G.5
Gemon, M.F.6
-
9
-
-
16644373167
-
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group
-
de Botton, S., Fawaz, A., Chevret, S., Dombret, H., Thomas, X., Sanz, M., Guerci, A., San Miguel, J., de la Serna, J., Stoppa, A.M., Reman, O., Stamatoulas, A., Fey, M., Cahn, J.Y., Sotto, J.J., Bourhis, J.H., Parry, A., Chomienne, C., Degos, L. & Fenaux, P. (2005) Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. Journal of Clinical Oncology, 23, 120-126.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 120-126
-
-
de Botton, S.1
Fawaz, A.2
Chevret, S.3
Dombret, H.4
Thomas, X.5
Sanz, M.6
Guerci, A.7
San Miguel, J.8
de la Serna, J.9
Stoppa, A.M.10
Reman, O.11
Stamatoulas, A.12
Fey, M.13
Cahn, J.Y.14
Sotto, J.J.15
Bourhis, J.H.16
Parry, A.17
Chomienne, C.18
Degos, L.19
Fenaux, P.20
more..
-
10
-
-
84901448095
-
Thrombo-hemorrhagic deaths in acute promyelocytic leukemia
-
Breccia, M. & Lo-Coco, F. (2014) Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. Thrombosis Research, 133, 112-116.
-
(2014)
Thrombosis Research
, vol.133
, pp. 112-116
-
-
Breccia, M.1
Lo-Coco, F.2
-
11
-
-
77952300646
-
Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation
-
Breccia, M., Latagliata, R., Cannella, L., Minotti, C., Meloni, G. & Lo-Coco, F. (2010) Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation. Haematologica, 95, 853-854.
-
(2010)
Haematologica
, vol.95
, pp. 853-854
-
-
Breccia, M.1
Latagliata, R.2
Cannella, L.3
Minotti, C.4
Meloni, G.5
Lo-Coco, F.6
-
12
-
-
80052385057
-
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia
-
Breccia, M., Cicconi, L., Minotti, C., Latagliata, R., Giannì, L. & Lo-Coco, F. (2011) Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemia. Haematologica, 96, 1390-1391.
-
(2011)
Haematologica
, vol.96
, pp. 1390-1391
-
-
Breccia, M.1
Cicconi, L.2
Minotti, C.3
Latagliata, R.4
Giannì, L.5
Lo-Coco, F.6
-
13
-
-
84876120195
-
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial
-
Burnett, A.K., Hills, R.K., Grimwade, D., Jovanovic, J.V., Craig, J., McMullin, M.F., Kell, J., Wheatley, K., Yin, J.A., Hunter, A., Milligan, D. & Russell, N.H.; United Kingdom National Cancer Research Institute Acute Myeloid Leukaemia Subgroup. (2013) Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. Leukemia, 27, 843-851.
-
(2013)
Leukemia
, vol.27
, pp. 843-851
-
-
Burnett, A.K.1
Hills, R.K.2
Grimwade, D.3
Jovanovic, J.V.4
Craig, J.5
McMullin, M.F.6
Kell, J.7
Wheatley, K.8
Yin, J.A.9
Hunter, A.10
Milligan, D.11
Russell, N.H.12
-
14
-
-
84948978098
-
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
-
Burnett, A., Russell, N.H., Hills, R.K., Bowen, D., Kell, J., Knapper, S., Morgan, Y.G., Lok, J., Grech, A., Jones, G., Khwaja, A., Friis, L., McMullin, M.F., Hunter, A., Clark, R.E. & Grimwade, D. (2015) Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. The Lancet Oncology, 16, 1295-1305.
-
(2015)
The Lancet Oncology
, vol.16
, pp. 1295-1305
-
-
Burnett, A.1
Russell, N.H.2
Hills, R.K.3
Bowen, D.4
Kell, J.5
Knapper, S.6
Morgan, Y.G.7
Lok, J.8
Grech, A.9
Jones, G.10
Khwaja, A.11
Friis, L.12
McMullin, M.F.13
Hunter, A.14
Clark, R.E.15
Grimwade, D.16
-
15
-
-
84861346428
-
Bleeding and thrombosis in acute promyelocytic leukemia
-
Choudhry, A. & DeLoughery, T.G. (2012) Bleeding and thrombosis in acute promyelocytic leukemia. American Journal of Hematology, 87, 596-603.
-
(2012)
American Journal of Hematology
, vol.87
, pp. 596-603
-
-
Choudhry, A.1
DeLoughery, T.G.2
-
16
-
-
33847178763
-
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention
-
Esteve, J., Escoda, L., Martin, G., Rubio, V., Diaz-Mediavilla, J., Gonzalez, M., Rivas, C., Alvarez, C., Gonzalez San Miguel, J.D., Brunet, S., Tomas, J.F., Tormo, M., Sayas, M.J., Sanchez Godoy, P., Colomer, D., Bolufer, P. & Sanz, M.A. (2007) Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention. Leukemia, 21, 446-452.
-
(2007)
Leukemia
, vol.21
, pp. 446-452
-
-
Esteve, J.1
Escoda, L.2
Martin, G.3
Rubio, V.4
Diaz-Mediavilla, J.5
Gonzalez, M.6
Rivas, C.7
Alvarez, C.8
Gonzalez San Miguel, J.D.9
Brunet, S.10
Tomas, J.F.11
Tormo, M.12
Sayas, M.J.13
Sanchez Godoy, P.14
Colomer, D.15
Bolufer, P.16
Sanz, M.A.17
-
17
-
-
33646386643
-
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
-
Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D. & Kantarjian, H. (2006) Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood, 107, 3469-3473.
-
(2006)
Blood
, vol.107
, pp. 3469-3473
-
-
Estey, E.1
Garcia-Manero, G.2
Ferrajoli, A.3
Faderl, S.4
Verstovsek, S.5
Jones, D.6
Kantarjian, H.7
-
18
-
-
0027368561
-
Effect of all trans-retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
-
Fenaux, P., Le Deley, M.C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M.T. & Bowen, D. (1993) Effect of all trans-retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood, 82, 3241-3249.
-
(1993)
Blood
, vol.82
, pp. 3241-3249
-
-
Fenaux, P.1
Le Deley, M.C.2
Castaigne, S.3
Archimbaud, E.4
Chomienne, C.5
Link, H.6
Guerci, A.7
Duarte, M.8
Daniel, M.T.9
Bowen, D.10
-
19
-
-
0033566639
-
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL group
-
Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL group. Blood, 94, 1192-1200.
-
(1999)
Blood
, vol.94
, pp. 1192-1200
-
-
Fenaux, P.1
Chastang, C.2
Chevret, S.3
Sanz, M.4
Dombret, H.5
Archimbaud, E.6
Fey, M.7
Rayon, C.8
Huguet, F.9
Sotto, J.J.10
Gardin, C.11
Makhoul, P.C.12
Travade, P.13
Solary, E.14
Fegueux, N.15
Bordessoule, D.16
Miguel, J.S.17
Link, H.18
Desablens, B.19
Stamatoullas, A.20
Deconinck, E.21
Maloisel, F.22
Castaigne, S.23
Preudhomme, C.24
Degos, L.25
more..
-
20
-
-
77958580267
-
Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission
-
Ferrara, F., Finizio, O., Izzo, T., Riccardi, C., Criscuolo, C., Carbone, A., Borlenghi, E. & Rossi, G. (2010) Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission. Anticancer Research, 30, 3845-3849.
-
(2010)
Anticancer Research
, vol.30
, pp. 3845-3849
-
-
Ferrara, F.1
Finizio, O.2
Izzo, T.3
Riccardi, C.4
Criscuolo, C.5
Carbone, A.6
Borlenghi, E.7
Rossi, G.8
-
21
-
-
0026647140
-
The "retinoic acid syndrome" in acute promyelocytic leukemia
-
Frankel, S.R. (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Annals of Internal Medicine, 117, 292-296.
-
(1992)
Annals of Internal Medicine
, vol.117
, pp. 292-296
-
-
Frankel, S.R.1
-
22
-
-
79960225126
-
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia
-
Ghavamzadeh, A., Alimoghaddam, K., Rostami, S., Ghaffari, S.H., Jahani, M., Iravani, M., Mousavi, S.A., Bahar, B. & Jalili, M. (2011) Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. Journal of Clinical Oncology, 29, 2753-2757.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 2753-2757
-
-
Ghavamzadeh, A.1
Alimoghaddam, K.2
Rostami, S.3
Ghaffari, S.H.4
Jahani, M.5
Iravani, M.6
Mousavi, S.A.7
Bahar, B.8
Jalili, M.9
-
23
-
-
77949889670
-
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia
-
Gore, S.D., Gojo, I., Sekeres, M.A., Morris, L., Devetten, M., Jamieson, K., Redner, R.L., Arceci, R., Owoeye, I., Dauses, T., Schachter-Tokarz, E. & Gallagher, R.E. (2010) Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. Journal of Clinical Oncology, 28, 1047-1053.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 1047-1053
-
-
Gore, S.D.1
Gojo, I.2
Sekeres, M.A.3
Morris, L.4
Devetten, M.5
Jamieson, K.6
Redner, R.L.7
Arceci, R.8
Owoeye, I.9
Dauses, T.10
Schachter-Tokarz, E.11
Gallagher, R.E.12
-
24
-
-
0032853710
-
The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease
-
Grimwade, D. (1999) The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. British Journal of Haematology, 106, 591-613.
-
(1999)
British Journal of Haematology
, vol.106
, pp. 591-613
-
-
Grimwade, D.1
-
25
-
-
0023752982
-
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
-
Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. & Wang, Z.Y. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
-
(1988)
Blood
, vol.72
, pp. 567-572
-
-
Huang, M.E.1
Ye, Y.C.2
Chen, S.R.3
Chai, J.R.4
Lu, J.X.5
Zhoa, L.6
Gu, L.J.7
Wang, Z.Y.8
-
26
-
-
84954529535
-
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomized phase 2 trial
-
Iland, H.J., Collins, M., Bradstock, K., Supple, S.G., Catalano, A., Hertzberg, M., Browett, P., Grigg, A., Firkin, F., Campbell, L.J., Hugman, A., Reynolds, J., Di Iulio, J., Tiley, C., Taylor, K., Filshie, R., Seldon, M., Taper, J., Szer, J., Moore, J., Bashford, J. & Seymour, J.F.; Australasian Leukaemia and Lymphoma Group. (2015) Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomized phase 2 trial. Lancet Haematology, 9, e357.
-
(2015)
Lancet Haematology
, vol.9
, pp. e357
-
-
Iland, H.J.1
Collins, M.2
Bradstock, K.3
Supple, S.G.4
Catalano, A.5
Hertzberg, M.6
Browett, P.7
Grigg, A.8
Firkin, F.9
Campbell, L.J.10
Hugman, A.11
Reynolds, J.12
Di Iulio, J.13
Tiley, C.14
Taylor, K.15
Filshie, R.16
Seldon, M.17
Taper, J.18
Szer, J.19
Moore, J.20
Bashford, J.21
Seymour, J.F.22
more..
-
27
-
-
77649188321
-
Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia
-
Kiguchi, T., Yoshino, Y., Yuan, B., Yoshizawa, S., Kitahara, T., Akahane, D., Gotoh, M., Kaise, T., Toyoda, H. & Ohyashiki, K. (2010) Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia. Leukemia Research, 34, 403-405.
-
(2010)
Leukemia Research
, vol.34
, pp. 403-405
-
-
Kiguchi, T.1
Yoshino, Y.2
Yuan, B.3
Yoshizawa, S.4
Kitahara, T.5
Akahane, D.6
Gotoh, M.7
Kaise, T.8
Toyoda, H.9
Ohyashiki, K.10
-
28
-
-
85027932070
-
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
-
Lehmann, S., Ravn, A., Carlsson, L., Antunovic, P., Deneberg, S., Mollgard, L., Derolf, A.R., Stockelberg, D., Tidefelt, U., Wahlin, A., Wennstrom, L., Hoglund, M. & Juliusson, G. (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia, 25, 1128-1134.
-
(2011)
Leukemia
, vol.25
, pp. 1128-1134
-
-
Lehmann, S.1
Ravn, A.2
Carlsson, L.3
Antunovic, P.4
Deneberg, S.5
Mollgard, L.6
Derolf, A.R.7
Stockelberg, D.8
Tidefelt, U.9
Wahlin, A.10
Wennstrom, L.11
Hoglund, M.12
Juliusson, G.13
-
29
-
-
27644459218
-
Treatment concepts of acute promyelocytic leukemia
-
Lengfelder, E., Saussele, S., Weisser, A., Buchner, T. & Hehlmann, R. (2005) Treatment concepts of acute promyelocytic leukemia. Critical Review Oncology Hematology, 56, 261-274.
-
(2005)
Critical Review Oncology Hematology
, vol.56
, pp. 261-274
-
-
Lengfelder, E.1
Saussele, S.2
Weisser, A.3
Buchner, T.4
Hehlmann, R.5
-
30
-
-
84857994331
-
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
-
Lengfelder, E., Hofmann, W.K. & Nowak, D. (2012) Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia, 26, 433-442.
-
(2012)
Leukemia
, vol.26
, pp. 433-442
-
-
Lengfelder, E.1
Hofmann, W.K.2
Nowak, D.3
-
31
-
-
84929280983
-
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
-
Lengfelder, E., Lo-Coco, F., Ades, L., Montesinos, P., Grimwade, D., Kishore, B., Ramadan, S.M., Pagoni, M., Breccia, M., Huerta, A.J., Nloga, A.M., González-Sanmiguel, J.D., Schmidt, A., Lambert, J.F., Lehmann, S., Di Bona, E., Cassinat, B., Hofmann, W.K., Görlich, D., Sauerland, M.C., Fenaux, P., Sanz, M.; European LeukemiaNet. (2015) Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet. Leukemia, 29, 1084-1091.
-
(2015)
Leukemia
, vol.29
, pp. 1084-1091
-
-
Lengfelder, E.1
Lo-Coco, F.2
Ades, L.3
Montesinos, P.4
Grimwade, D.5
Kishore, B.6
Ramadan, S.M.7
Pagoni, M.8
Breccia, M.9
Huerta, A.J.10
Nloga, A.M.11
González-Sanmiguel, J.D.12
Schmidt, A.13
Lambert, J.F.14
Lehmann, S.15
Di Bona, E.16
Cassinat, B.17
Hofmann, W.K.18
Görlich, D.19
Sauerland, M.C.20
Fenaux, P.21
Sanz, M.22
more..
-
32
-
-
0033214651
-
Therapy of molecular relapse in acute promyelocytic leukemia
-
Lo-Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G. & Mandelli, F. (1999) Therapy of molecular relapse in acute promyelocytic leukemia. Blood, 94, 2225-2229.
-
(1999)
Blood
, vol.94
, pp. 2225-2229
-
-
Lo-Coco, F.1
Diverio, D.2
Avvisati, G.3
Petti, M.C.4
Meloni, G.5
Pogliani, E.M.6
Biondi, A.7
Rossi, G.8
Carlo-Stella, C.9
Selleri, C.10
Martino, B.11
Specchia, G.12
Mandelli, F.13
-
33
-
-
77958499078
-
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA group
-
Lo-Coco, F., Avvisati, G., Vignetti, M., Breccia, M., Gallo, E., Rambaldi, A., Paoloni, F., Fioritoni, G., Ferrara, F., Specchia, G., Cimino, G., Diverio, D., Borlenghi, E., Martinelli, G., Di Raimondo, F., Di Bona, E., Fazi, P., Peta, A., Bosi, A., Carella, A.M., Fabbiano, F., Pogliani, E.M., Petti, M.C., Amadori, S. & Mandelli, F.; Italian GIMEMA Cooperative Group. (2010) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA group. Blood, 116, 3171-3179.
-
(2010)
Blood
, vol.116
, pp. 3171-3179
-
-
Lo-Coco, F.1
Avvisati, G.2
Vignetti, M.3
Breccia, M.4
Gallo, E.5
Rambaldi, A.6
Paoloni, F.7
Fioritoni, G.8
Ferrara, F.9
Specchia, G.10
Cimino, G.11
Diverio, D.12
Borlenghi, E.13
Martinelli, G.14
Di Raimondo, F.15
Di Bona, E.16
Fazi, P.17
Peta, A.18
Bosi, A.19
Carella, A.M.20
Fabbiano, F.21
Pogliani, E.M.22
Petti, M.C.23
Amadori, S.24
Mandelli, F.25
more..
-
34
-
-
84880287051
-
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
-
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S.M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., Specchia, G., Sica, S., Divona, M., Levis, A., Fiedler, W., Cerqui, E., Breccia, M., Fioritoni, G., Salih, H.R., Cazzola, M., Melillo, L., Carella, A.M., Brandts, C.H., Morra, E., von Lilienfeld-Toal, M., Hertenstein, B., Wattad, M., Lübbert, M., Hänel, M., Schmitz, N., Link, H., Kropp, M.G., Rambaldi, A., La Nasa, G., Luppi, M., Ciceri, F., Finizio, O., Venditti, A., Fabbiano, F., Döhner, K., Sauer, M., Ganser, A., Amadori, S., Mandelli, F., Döhner, H., Ehninger, G., Schlenk, R.F. & Platzbecker, U.; Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia. (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. New England Journal of Medicine, 369, 111-121.
-
(2013)
New England Journal of Medicine
, vol.369
, pp. 111-121
-
-
Lo-Coco, F.1
Avvisati, G.2
Vignetti, M.3
Thiede, C.4
Orlando, S.M.5
Iacobelli, S.6
Ferrara, F.7
Fazi, P.8
Cicconi, L.9
Di Bona, E.10
Specchia, G.11
Sica, S.12
Divona, M.13
Levis, A.14
Fiedler, W.15
Cerqui, E.16
Breccia, M.17
Fioritoni, G.18
Salih, H.R.19
Cazzola, M.20
Melillo, L.21
Carella, A.M.22
Brandts, C.H.23
Morra, E.24
von Lilienfeld-Toal, M.25
Hertenstein, B.26
Wattad, M.27
Lübbert, M.28
Hänel, M.29
Schmitz, N.30
Link, H.31
Kropp, M.G.32
Rambaldi, A.33
La Nasa, G.34
Luppi, M.35
Ciceri, F.36
Finizio, O.37
Venditti, A.38
Fabbiano, F.39
Döhner, K.40
Sauer, M.41
Ganser, A.42
Amadori, S.43
Mandelli, F.44
Döhner, H.45
Ehninger, G.46
Schlenk, R.F.47
Platzbecker, U.48
more..
-
35
-
-
84902304171
-
Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
-
Lou, Y., Suo, S., Tong, Y., Tong, H., Qian, W., Meng, H., Mai, W., Huang, J., Yu, W. & Jin, J. (2014) Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy. Annals of Hematology, 93, 941-948.
-
(2014)
Annals of Hematology
, vol.93
, pp. 941-948
-
-
Lou, Y.1
Suo, S.2
Tong, Y.3
Tong, H.4
Qian, W.5
Meng, H.6
Mai, W.7
Huang, J.8
Yu, W.9
Jin, J.10
-
36
-
-
0030825408
-
Molecular remission in PML/RAR alpha - positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano Malattie Ematologiche dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
-
Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo-Coco, F. (1997) Molecular remission in PML/RAR alpha - positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano Malattie Ematologiche dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 90, 1014-1021.
-
(1997)
Blood
, vol.90
, pp. 1014-1021
-
-
Mandelli, F.1
Diverio, D.2
Avvisati, G.3
Luciano, A.4
Barbui, T.5
Bernasconi, C.6
Broccia, G.7
Cerri, R.8
Falda, M.9
Fioritoni, G.10
Leoni, F.11
Liso, V.12
Petti, M.C.13
Rodeghiero, F.14
Saglio, G.15
Vegna, M.L.16
Visani, G.17
Jehn, U.18
Willemze, R.19
Muus, P.20
Pelicci, P.G.21
Biondi, A.22
Lo-Coco, F.23
more..
-
37
-
-
77956251955
-
Single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data
-
Mathews, V., George, B., Chendamarai, E., Lakshmi, K.M., Desire, S., Balasubramanian, P., Viswabandya, A., Thirugnanam, R., Abraham, A., Shaji, R.V., Srivastava, A. & Chandy, M. (2010) Single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. Journal of Clinical Oncology, 28, 3866-3871.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 3866-3871
-
-
Mathews, V.1
George, B.2
Chendamarai, E.3
Lakshmi, K.M.4
Desire, S.5
Balasubramanian, P.6
Viswabandya, A.7
Thirugnanam, R.8
Abraham, A.9
Shaji, R.V.10
Srivastava, A.11
Chandy, M.12
-
38
-
-
84855231183
-
Treatment advances have not improved the early death rate in acute promyelocytic leukemia
-
McClellan, J.S., Kohrt, H.E., Coutre, S., Gotlib, J.R., Majeti, R., Alizadeh, A.A. & Medeiros, B.C. (2012) Treatment advances have not improved the early death rate in acute promyelocytic leukemia. Haematologica, 97, 133-136.
-
(2012)
Haematologica
, vol.97
, pp. 133-136
-
-
McClellan, J.S.1
Kohrt, H.E.2
Coutre, S.3
Gotlib, J.R.4
Majeti, R.5
Alizadeh, A.A.6
Medeiros, B.C.7
-
39
-
-
33750148809
-
Guidelines on the management of acute myeloid leukemia in adults
-
Milligan, D.W., Grimwade, D., Cullis, J.O., Bond, L., Swirsky, D., Craddock, C., Kell, J., Homewood, J., Campbell, K., McGinley, S., Wheatley, K., Jackson, G.; for the British Committee for Standards in Haematology. (2006) Guidelines on the management of acute myeloid leukemia in adults. British Journal of Haematology, 135, 450-474.
-
(2006)
British Journal of Haematology
, vol.135
, pp. 450-474
-
-
Milligan, D.W.1
Grimwade, D.2
Cullis, J.O.3
Bond, L.4
Swirsky, D.5
Craddock, C.6
Kell, J.7
Homewood, J.8
Campbell, K.9
McGinley, S.10
Wheatley, K.11
Jackson, G.12
-
40
-
-
70349124202
-
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis
-
Montesinos, P., Díaz-Mediavilla, J., Debén, G., Prates, V., Tormo, M., Rubio, V., Pérez, I., Fernández, I., Viguria, M., Rayón, C., González, J., de la Serna, J., Esteve, J., Bergua, J.M., Rivas, C., González, M., González, J.D., Negri, S., Brunet, S., Lowenberg, B. & Sanz, M.A. (2009) Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica, 94, 1242-1249.
-
(2009)
Haematologica
, vol.94
, pp. 1242-1249
-
-
Montesinos, P.1
Díaz-Mediavilla, J.2
Debén, G.3
Prates, V.4
Tormo, M.5
Rubio, V.6
Pérez, I.7
Fernández, I.8
Viguria, M.9
Rayón, C.10
González, J.11
de la Serna, J.12
Esteve, J.13
Bergua, J.M.14
Rivas, C.15
González, M.16
González, J.D.17
Negri, S.18
Brunet, S.19
Lowenberg, B.20
Sanz, M.A.21
more..
-
41
-
-
84960188995
-
-
NCCN guidelines "Acute myeloid leukemia", version 1.2015. National Comprehensive Cancer Network, Fort Washington, PA. Available at:. [Accessed December 3, 2014].
-
NCCN (2015) NCCN guidelines "Acute myeloid leukemia", version 1.2015. National Comprehensive Cancer Network, Fort Washington, PA. Available at: http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf. [Accessed December 3, 2014].
-
(2015)
-
-
-
42
-
-
35348907310
-
PML-RARalpha inhibitors (ATRA, tamibarotene, arsenic trioxide) for acute promyelocytic leukemia
-
Ohnishi, K. (2007) PML-RARalpha inhibitors (ATRA, tamibarotene, arsenic trioxide) for acute promyelocytic leukemia. International Journal of Clinical Oncology, 12, 313-317.
-
(2007)
International Journal of Clinical Oncology
, vol.12
, pp. 313-317
-
-
Ohnishi, K.1
-
43
-
-
0034610263
-
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia
-
Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., Sugiyama, S., Satoh, H., Terada, H. & Ohno, R. (2000) Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Annals of Internal Medicine, 133, 881-885.
-
(2000)
Annals of Internal Medicine
, vol.133
, pp. 881-885
-
-
Ohnishi, K.1
Yoshida, H.2
Shigeno, K.3
Nakamura, S.4
Fujisawa, S.5
Naito, K.6
Shinjo, K.7
Fujita, Y.8
Matsui, H.9
Takeshita, A.10
Sugiyama, S.11
Satoh, H.12
Terada, H.13
Ohno, R.14
-
44
-
-
0041327727
-
Expression of cell-surface antigens in acute promyelocytic leukaemia
-
Paietta, E. (2003) Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Practice Research in Clinical Haematology, 16, 369-385.
-
(2003)
Best Practice Research in Clinical Haematology
, vol.16
, pp. 369-385
-
-
Paietta, E.1
-
45
-
-
79961092821
-
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
-
Park, J.H., Qiao, B., Panageas, K.S., Schymura, M.J., Jurcic, J.G., Rosenblat, T.L., Altman, J.K., Douer, D., Rowe, J.M. & Tallman, M.S. (2011) Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood, 118, 1248-1254.
-
(2011)
Blood
, vol.118
, pp. 1248-1254
-
-
Park, J.H.1
Qiao, B.2
Panageas, K.S.3
Schymura, M.J.4
Jurcic, J.G.5
Rosenblat, T.L.6
Altman, J.K.7
Douer, D.8
Rowe, J.M.9
Tallman, M.S.10
-
46
-
-
84905968346
-
Acute promyelocytic leukemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukemia referral centres: a pan-Canadian epidemiological study
-
Paulson, K., Serebrin, A., Lambert, P., Bergeron, J., Everett, J., Kew, A., Jones, D., Mahmud, S., Meloche, C., Sabloff, M., Sharif, I., Storring, J., Turner, D. & Seftel, M.D. (2014) Acute promyelocytic leukemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukemia referral centres: a pan-Canadian epidemiological study. British Journal of Haematology, 166, 660-666.
-
(2014)
British Journal of Haematology
, vol.166
, pp. 660-666
-
-
Paulson, K.1
Serebrin, A.2
Lambert, P.3
Bergeron, J.4
Everett, J.5
Kew, A.6
Jones, D.7
Mahmud, S.8
Meloche, C.9
Sabloff, M.10
Sharif, I.11
Storring, J.12
Turner, D.13
Seftel, M.D.14
-
47
-
-
0023225760
-
Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients
-
Petti, M.C., Avvisati, G., Amadori, S., Baccarani, M., Guarini, A.R., Papa, G., Rosti, G.A., Tura, S. & Mandelli, F. (1987) Acute promyelocytic leukemia: clinical aspects and results of treatment in 62 patients. Haematologica, 72, 151-155.
-
(1987)
Haematologica
, vol.72
, pp. 151-155
-
-
Petti, M.C.1
Avvisati, G.2
Amadori, S.3
Baccarani, M.4
Guarini, A.R.5
Papa, G.6
Rosti, G.A.7
Tura, S.8
Mandelli, F.9
-
48
-
-
84930345720
-
Improved outcome with ATRA-arsenic trioxide compared to ATRA-chemotherapy in non-high risk acute promyelocytic leukemia - updated results of the Italian-German APL0406 Trial on the Extended Final Series
-
Platzbecker, U., Avvisati, G., Ehninger, G., Cicconi, L., Thiede, C., Ferrara, F., Orlando, S.M., Vignetti, M., Specchia, G., Sborgia, M., Di Bona, E., Breccia, M., Cerqui, E., Döhner, K., Fiedler, W., von Lilienfeld-Toal, M., Hertenstein, B., Salih, H.R., Wattad, M., Lübbert, M., Brandts, C.H., Hänel, M., Schmitz, N., Link, H., Divona, M., Frairia, C., Pogliani, E.M., Fozza, C., D'Arco, A.M., Di Renzo, N., Cortelezzi, A., Fabbiano, F., Fazi, P., Kullmer, J., Aulitzky, W.E., Krause, S.W., Salwender, H., Schäfer-Eckart, K., Radsak, M.P., Ganser, A., Döhner, H., Amadori, S., Mandelli, F., Schlenk, R.F. & Lo-Coco, F. (2014) Improved outcome with ATRA-arsenic trioxide compared to ATRA-chemotherapy in non-high risk acute promyelocytic leukemia - updated results of the Italian-German APL0406 Trial on the Extended Final Series. Blood (ASH Annual Meeting Abstracts), 124, 12.
-
(2014)
Blood (ASH Annual Meeting Abstracts)
, vol.124
, pp. 12
-
-
Platzbecker, U.1
Avvisati, G.2
Ehninger, G.3
Cicconi, L.4
Thiede, C.5
Ferrara, F.6
Orlando, S.M.7
Vignetti, M.8
Specchia, G.9
Sborgia, M.10
Di Bona, E.11
Breccia, M.12
Cerqui, E.13
Döhner, K.14
Fiedler, W.15
von Lilienfeld-Toal, M.16
Hertenstein, B.17
Salih, H.R.18
Wattad, M.19
Lübbert, M.20
Brandts, C.H.21
Hänel, M.22
Schmitz, N.23
Link, H.24
Divona, M.25
Frairia, C.26
Pogliani, E.M.27
Fozza, C.28
D'Arco, A.M.29
Di Renzo, N.30
Cortelezzi, A.31
Fabbiano, F.32
Fazi, P.33
Kullmer, J.34
Aulitzky, W.E.35
Krause, S.W.36
Salwender, H.37
Schäfer-Eckart, K.38
Radsak, M.P.39
Ganser, A.40
Döhner, H.41
Amadori, S.42
Mandelli, F.43
Schlenk, R.F.44
Lo-Coco, F.45
more..
-
49
-
-
77958456360
-
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
-
Powell, B.L., Moser, B., Stock, W., Gallagher, R.E., Willman, C.L., Stone, R.M., Rowe, J.M., Coutre, S., Feusner, J.H., Gregory, J., Couban, S., Appelbaum, F.R., Tallman, M.S. & Larson, R.A. (2010) Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood, 116, 3751-3757.
-
(2010)
Blood
, vol.116
, pp. 3751-3757
-
-
Powell, B.L.1
Moser, B.2
Stock, W.3
Gallagher, R.E.4
Willman, C.L.5
Stone, R.M.6
Rowe, J.M.7
Coutre, S.8
Feusner, J.H.9
Gregory, J.10
Couban, S.11
Appelbaum, F.R.12
Tallman, M.S.13
Larson, R.A.14
-
50
-
-
84868557000
-
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era
-
Ramadan, S.M., Di Veroli, A., Camboni, A., Breccia, M., Iori, A.P., Aversa, F., Cupelli, L., Papayannidis, C., Bacigalupo, A., Arcese, W. & Lo-Coco, F. (2012) Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era. Haematologica, 97, 1731-1735.
-
(2012)
Haematologica
, vol.97
, pp. 1731-1735
-
-
Ramadan, S.M.1
Di Veroli, A.2
Camboni, A.3
Breccia, M.4
Iori, A.P.5
Aversa, F.6
Cupelli, L.7
Papayannidis, C.8
Bacigalupo, A.9
Arcese, W.10
Lo-Coco, F.11
-
51
-
-
59149089411
-
Effective treatment of acute promyelocytic leukemia with all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin
-
Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., Ferrajoli, A., Verstovsek, S., Garcia-Manero, G., Cortes, J. & Kantarjian, H. (2009) Effective treatment of acute promyelocytic leukemia with all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. Journal of Clinical Oncology, 27, 504-510.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 504-510
-
-
Ravandi, F.1
Estey, E.2
Jones, D.3
Faderl, S.4
O'Brien, S.5
Fiorentino, J.6
Pierce, S.7
Blamble, D.8
Estrov, Z.9
Wierda, W.10
Ferrajoli, A.11
Verstovsek, S.12
Garcia-Manero, G.13
Cortes, J.14
Kantarjian, H.15
-
52
-
-
84869434807
-
Gemtuzumab ozogamicin: time to resurrect?
-
Ravandi, F., Estey, E.H., Appelbaum, F.R., Lo-Coco, F., Schiffer, C.A., Larson, R.A., Burnett, A.K. & Kantarjian, H.M. (2012) Gemtuzumab ozogamicin: time to resurrect? Journal of Clinical Oncology, 30, 3921-3923.
-
(2012)
Journal of Clinical Oncology
, vol.30
, pp. 3921-3923
-
-
Ravandi, F.1
Estey, E.H.2
Appelbaum, F.R.3
Lo-Coco, F.4
Schiffer, C.A.5
Larson, R.A.6
Burnett, A.K.7
Kantarjian, H.M.8
-
53
-
-
84911420075
-
Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide
-
Roboz, G.J., Ritchie, E.K., Carlin, R.F., Samuel, M., Gale, L., Provenzano-Gober, J.L., Curcio, T.J., Feldman, E.J. & Kligfield, P.D. (2014) Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide. Journal of Clinical Oncology, 32, 3723-3728.
-
(2014)
Journal of Clinical Oncology
, vol.32
, pp. 3723-3728
-
-
Roboz, G.J.1
Ritchie, E.K.2
Carlin, R.F.3
Samuel, M.4
Gale, L.5
Provenzano-Gober, J.L.6
Curcio, T.J.7
Feldman, E.J.8
Kligfield, P.D.9
-
54
-
-
84945442830
-
Tamibarotene in patients with acute promyelocytic leukemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide
-
Sanford, D., Lo-Coco, F., Sanz, M.A., Di Bona, E., Coutre, S., Altman, J.K., Wetzler, M., Allen, S.L., Ravandi, F., Kantarjian, H. & Cortes, J.E. (2015) Tamibarotene in patients with acute promyelocytic leukemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide. British Journal of Haematology, 171, 471-477.
-
(2015)
British Journal of Haematology
, vol.171
, pp. 471-477
-
-
Sanford, D.1
Lo-Coco, F.2
Sanz, M.A.3
Di Bona, E.4
Coutre, S.5
Altman, J.K.6
Wetzler, M.7
Allen, S.L.8
Ravandi, F.9
Kantarjian, H.10
Cortes, J.E.11
-
55
-
-
84905005458
-
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population based study
-
Sant, M., Minicozzi, P., Mounier, M., Anderson, L.A., Brenner, H., Holleczek, B., Marcos-Gragera, R., Maynadié, M., Monnereau, A., Osca-Gelis, G., Visser, O. & De Angelis, R.; EUROCARE-5 Working Group. (2014) Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population based study. Lancet Oncology, 15, 931-942.
-
(2014)
Lancet Oncology
, vol.15
, pp. 931-942
-
-
Sant, M.1
Minicozzi, P.2
Mounier, M.3
Anderson, L.A.4
Brenner, H.5
Holleczek, B.6
Marcos-Gragera, R.7
Maynadié, M.8
Monnereau, A.9
Osca-Gelis, G.10
Visser, O.11
De Angelis, R.12
-
56
-
-
79952079063
-
Modern approaches to treating acute promyelocytic leukemia
-
Sanz, M.A. & Lo-Coco, F. (2011) Modern approaches to treating acute promyelocytic leukemia. Journal of Clinical Oncology, 29, 495-503.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 495-503
-
-
Sanz, M.A.1
Lo-Coco, F.2
-
57
-
-
0033230342
-
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia PETHEMA group
-
Sanz, M.A., Martín, G., Rayón, C., Esteve, J., González, M., Díaz-Mediavilla, J., Bolufer, P., Barragán, E., Terol, M.J., González, J.D., Colomer, D., Chillón, C., Rivas, C., Gómez, T., Ribera, J.M., Bornstein, R., Román, J., Calasanz, M.J., Arias, J., Alvarez, C., Ramos, F. & Debén, G. (1999) A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia PETHEMA group. Blood, 94, 3015-3021.
-
(1999)
Blood
, vol.94
, pp. 3015-3021
-
-
Sanz, M.A.1
Martín, G.2
Rayón, C.3
Esteve, J.4
González, M.5
Díaz-Mediavilla, J.6
Bolufer, P.7
Barragán, E.8
Terol, M.J.9
González, J.D.10
Colomer, D.11
Chillón, C.12
Rivas, C.13
Gómez, T.14
Ribera, J.M.15
Bornstein, R.16
Román, J.17
Calasanz, M.J.18
Arias, J.19
Alvarez, C.20
Ramos, F.21
Debén, G.22
more..
-
58
-
-
0034663162
-
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
-
Sanz, M.A., Lo-Coco, F., Martín, G., Avvisati, G., Rayón, C., Barbui, T., Díaz-Mediavilla, J., Fioritoni, G., González, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247-1253.
-
(2000)
Blood
, vol.96
, pp. 1247-1253
-
-
Sanz, M.A.1
Lo-Coco, F.2
Martín, G.3
Avvisati, G.4
Rayón, C.5
Barbui, T.6
Díaz-Mediavilla, J.7
Fioritoni, G.8
González, J.D.9
Liso, V.10
Esteve, J.11
Ferrara, F.12
Bolufer, P.13
Bernasconi, C.14
Gonzalez, M.15
Rodeghiero, F.16
Colomer, D.17
Petti, M.C.18
Ribera, J.M.19
Mandelli, F.20
more..
-
59
-
-
10744220024
-
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicentre study by the PETHEMA group
-
Sanz, M.A., Martín, G., González, M., León, A., Rayón, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., De La Serna, J., Román, J., Barragán, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J., Bolufer, P.; Programa de Estudio y Traitmiento de las Hemopatías Malignas. (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicentre study by the PETHEMA group. Blood, 103, 1237-1243.
-
(2004)
Blood
, vol.103
, pp. 1237-1243
-
-
Sanz, M.A.1
Martín, G.2
González, M.3
León, A.4
Rayón, C.5
Rivas, C.6
Colomer, D.7
Amutio, E.8
Capote, F.J.9
Milone, G.A.10
De La Serna, J.11
Román, J.12
Barragán, E.13
Bergua, J.14
Escoda, L.15
Parody, R.16
Negri, S.17
Calasanz, M.J.18
Bolufer, P.19
-
60
-
-
34247274207
-
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation
-
Sanz, M.A., Labopin, M., Gorin, N.C., de la Rubia, J., Arcese, W., Meloni, G., Bacigalupo, A., Alessandrino, P., Carreras, E., Iriondo, A., Novitzky, N., Jacobs, P., Bandini, G., Lo-Coco, F., Frassoni, F. & Rocha, V.; Acute Leukemia Working Party (ALWP) of European Cooperative Group for Blood and Marrow Transplantation (EBMT). (2007) Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 39, 461-469.
-
(2007)
Bone Marrow Transplantation
, vol.39
, pp. 461-469
-
-
Sanz, M.A.1
Labopin, M.2
Gorin, N.C.3
de la Rubia, J.4
Arcese, W.5
Meloni, G.6
Bacigalupo, A.7
Alessandrino, P.8
Carreras, E.9
Iriondo, A.10
Novitzky, N.11
Jacobs, P.12
Bandini, G.13
Lo-Coco, F.14
Frassoni, F.15
Rocha, V.16
-
61
-
-
54049087434
-
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA99 multicenter study by the PETHEMA Group
-
Sanz, M.A., Montesinos, P., Vellenga, E., Rayón, C., de la Serna, J., Parody, R., Bergua, J.M., León, A., Negri, S., González, M., Rivas, C., Esteve, J., Milone, G., González, J.D., Amutio, E., Brunet, S., García-Laraña, J., Colomer, D., Calasanz, M.J., Chillón, C., Barragán, E., Bolufer, P. & Lowenberg, B. (2008) Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA99 multicenter study by the PETHEMA Group. Blood, 112, 3130-3134.
-
(2008)
Blood
, vol.112
, pp. 3130-3134
-
-
Sanz, M.A.1
Montesinos, P.2
Vellenga, E.3
Rayón, C.4
de la Serna, J.5
Parody, R.6
Bergua, J.M.7
León, A.8
Negri, S.9
González, M.10
Rivas, C.11
Esteve, J.12
Milone, G.13
González, J.D.14
Amutio, E.15
Brunet, S.16
García-Laraña, J.17
Colomer, D.18
Calasanz, M.J.19
Chillón, C.20
Barragán, E.21
Bolufer, P.22
Lowenberg, B.23
more..
-
62
-
-
61949441174
-
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
-
Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Buchner, T., Dohner, H., Burnett, A.K. & Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 113, 1875-1891.
-
(2009)
Blood
, vol.113
, pp. 1875-1891
-
-
Sanz, M.A.1
Grimwade, D.2
Tallman, M.S.3
Lowenberg, B.4
Fenaux, P.5
Estey, E.H.6
Naoe, T.7
Lengfelder, E.8
Buchner, T.9
Dohner, H.10
Burnett, A.K.11
Lo-Coco, F.12
-
63
-
-
84941038904
-
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
-
Sanz, M.A., Montesinos, P., Kim, H.T., Ruiz-Argüelles, G.J., Undurraga, M.S., Uriarte, M.R., Martínez, L., Jacomo, R.H., Gutiérrez-Aguirre, H., Melo, R.A., Bittencourt, R., Pasquini, R., Pagnano, K., Fagundes, E.M., Vellenga, E., Holowiecka, A., González- Huerta, A.J., Fernández, P., De la Serna, J., Brunet, S., De Lisa, E., González-Campos, J., Ribera, J.M., Krsnik, I., Ganser, A., Berliner, N., Ribeiro, R.C., Lo-Coco, F., Löwenberg, B. & Rego, E.M.; IC-APL and PETHEMA and HOVON Groups. (2015) All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, 94, 1347-1356.
-
(2015)
Annals of Hematology
, vol.94
, pp. 1347-1356
-
-
Sanz, M.A.1
Montesinos, P.2
Kim, H.T.3
Ruiz-Argüelles, G.J.4
Undurraga, M.S.5
Uriarte, M.R.6
Martínez, L.7
Jacomo, R.H.8
Gutiérrez-Aguirre, H.9
Melo, R.A.10
Bittencourt, R.11
Pasquini, R.12
Pagnano, K.13
Fagundes, E.M.14
Vellenga, E.15
Holowiecka, A.16
González-Huerta, A.J.17
Fernández, P.18
De la Serna, J.19
Brunet, S.20
De Lisa, E.21
González-Campos, J.22
Ribera, J.M.23
Krsnik, I.24
Ganser, A.25
Berliner, N.26
Ribeiro, R.C.27
Lo-Coco, F.28
Löwenberg, B.29
Rego, E.M.30
more..
-
64
-
-
84907806243
-
A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults
-
Seftel, M.D., Barnett, M.J., Couban, S., Leber, B., Storring, J., Assaily, W., Fuerth, B., Christofides, A. & Schuh, A.C. (2014) A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults. Current Oncology, 21, 234-250.
-
(2014)
Current Oncology
, vol.21
, pp. 234-250
-
-
Seftel, M.D.1
Barnett, M.J.2
Couban, S.3
Leber, B.4
Storring, J.5
Assaily, W.6
Fuerth, B.7
Christofides, A.8
Schuh, A.C.9
-
65
-
-
0030610687
-
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
-
Shen, Z.X., Chen, G.Q., Ni, J.H., Li, X.S., Xiong, S.M., Qiu, Q.Y., Zhu, J., Tang, W., Sun, G.L., Yang, K.Q., Chen, Y., Zhou, L., Fang, Z.W., Wang, Y.T., Ma, J., Zhang, P., Zhang, T.D., Chen, S.J., Chen, Z. & Wang, Z.Y. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354-3360.
-
(1997)
Blood
, vol.89
, pp. 3354-3360
-
-
Shen, Z.X.1
Chen, G.Q.2
Ni, J.H.3
Li, X.S.4
Xiong, S.M.5
Qiu, Q.Y.6
Zhu, J.7
Tang, W.8
Sun, G.L.9
Yang, K.Q.10
Chen, Y.11
Zhou, L.12
Fang, Z.W.13
Wang, Y.T.14
Ma, J.15
Zhang, P.16
Zhang, T.D.17
Chen, S.J.18
Chen, Z.19
Wang, Z.Y.20
more..
-
66
-
-
11144355810
-
All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
-
Shen, Z.X., Shi, Z.Z., Fang, J., Gu, B.W., Li, J.M., Zhu, Y.M., Shi, J.Y., Zheng, P.Z., Yan, H., Liu, Y.F., Chen, Y., Shen, Y., Wu, W., Tang, W., Waxman, S., De Thé, H., Wang, Z.Y., Chen, S.J. & Chen, Z. (2004) All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 101, 5328-5335.
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, pp. 5328-5335
-
-
Shen, Z.X.1
Shi, Z.Z.2
Fang, J.3
Gu, B.W.4
Li, J.M.5
Zhu, Y.M.6
Shi, J.Y.7
Zheng, P.Z.8
Yan, H.9
Liu, Y.F.10
Chen, Y.11
Shen, Y.12
Wu, W.13
Tang, W.14
Waxman, S.15
De Thé, H.16
Wang, Z.Y.17
Chen, S.J.18
Chen, Z.19
-
67
-
-
84906656419
-
Tamibarotene as maintenance therapy for acute promyelocytic leukemia: results from a randomized controlled trial
-
Shinagawa, K., Yanada, M., Sakura, T., Ueda, Y., Sawa, M., Miyatake, J., Dobashi, N., Kojima, M., Hatta, Y., Emi, N., Tamaki, S., Gomyo, H., Yamazaki, E., Fujimaki, K., Asou, N., Matsuo, K., Ohtake, S., Miyazaki, Y., Ohnishi, K., Kobayashi, Y. & Naoe, T. (2014) Tamibarotene as maintenance therapy for acute promyelocytic leukemia: results from a randomized controlled trial. Journal of Clinical Oncology, 32, 3729-3735.
-
(2014)
Journal of Clinical Oncology
, vol.32
, pp. 3729-3735
-
-
Shinagawa, K.1
Yanada, M.2
Sakura, T.3
Ueda, Y.4
Sawa, M.5
Miyatake, J.6
Dobashi, N.7
Kojima, M.8
Hatta, Y.9
Emi, N.10
Tamaki, S.11
Gomyo, H.12
Yamazaki, E.13
Fujimaki, K.14
Asou, N.15
Matsuo, K.16
Ohtake, S.17
Miyazaki, Y.18
Ohnishi, K.19
Kobayashi, Y.20
Naoe, T.21
more..
-
68
-
-
0035884639
-
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
-
Soignet, S.L., Frankel, S.R., Douer, D., Tallman, M.S., Kantarjian, H., Calleja, E., Stone, R.M., Kalaycio, M., Scheinberg, D.A., Steinherz, P., Sievers, E.L., Coutré, S., Dahlberg, S., Ellison, R. & Warrell, Jr, R.P. (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Journal of Clinical Oncology, 19, 3852-3860.
-
(2001)
Journal of Clinical Oncology
, vol.19
, pp. 3852-3860
-
-
Soignet, S.L.1
Frankel, S.R.2
Douer, D.3
Tallman, M.S.4
Kantarjian, H.5
Calleja, E.6
Stone, R.M.7
Kalaycio, M.8
Scheinberg, D.A.9
Steinherz, P.10
Sievers, E.L.11
Coutré, S.12
Dahlberg, S.13
Ellison, R.14
Warrell, R.P.15
-
69
-
-
3042629830
-
Curative therapeutic approaches to APL
-
Tallman, M.S. (2004) Curative therapeutic approaches to APL. Annals of Hematology, 83, S81-S82.
-
(2004)
Annals of Hematology
, vol.83
, pp. S81-S82
-
-
Tallman, M.S.1
-
70
-
-
73949097021
-
How I treat acute promyelocytic leukemia
-
Tallman, M.S. & Altman, J.K. (2009) How I treat acute promyelocytic leukemia. Blood, 114, 5126-5135.
-
(2009)
Blood
, vol.114
, pp. 5126-5135
-
-
Tallman, M.S.1
Altman, J.K.2
-
71
-
-
0037115195
-
All-trans retinoic acid in acute promyelocytci leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
-
Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Woods, W.G., Ogden, A., Weinstein, H., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (2002) All-trans retinoic acid in acute promyelocytci leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood, 100, 4298-4302.
-
(2002)
Blood
, vol.100
, pp. 4298-4302
-
-
Tallman, M.S.1
Andersen, J.W.2
Schiffer, C.A.3
Appelbaum, F.R.4
Feusner, J.H.5
Woods, W.G.6
Ogden, A.7
Weinstein, H.8
Shepherd, L.9
Willman, C.10
Bloomfield, C.D.11
Rowe, J.M.12
Wiernik, P.H.13
-
72
-
-
77958510339
-
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
-
de Thé, H. & Chen, Z. (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nature Reviews Cancer, 10, 775-783.
-
(2010)
Nature Reviews Cancer
, vol.10
, pp. 775-783
-
-
de Thé, H.1
Chen, Z.2
-
73
-
-
84865074686
-
The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies
-
de Thé, H., Le Bras, M. & Lallemand-Breitenbach, V. (2012) The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. Journal of Cell Biology, 198, 11-21.
-
(2012)
Journal of Cell Biology
, vol.198
, pp. 11-21
-
-
de Thé, H.1
Le Bras, M.2
Lallemand-Breitenbach, V.3
-
74
-
-
70350621606
-
Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen
-
Thirugnanam, R., George, B., Chendamarai, E., Lakshmi, K.M., Balasubramanian, P., Viswabandya, A., Srivastava, A., Chandy, M. & Mathews, V. (2009) Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biology of Blood Marrow Transplantation, 15, 1479-1484.
-
(2009)
Biology of Blood Marrow Transplantation
, vol.15
, pp. 1479-1484
-
-
Thirugnanam, R.1
George, B.2
Chendamarai, E.3
Lakshmi, K.M.4
Balasubramanian, P.5
Viswabandya, A.6
Srivastava, A.7
Chandy, M.8
Mathews, V.9
-
75
-
-
0030738326
-
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid
-
Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T. & Ohno, R. (1997) Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood, 90, 967-973.
-
(1997)
Blood
, vol.90
, pp. 967-973
-
-
Tobita, T.1
Takeshita, A.2
Kitamura, K.3
Ohnishi, K.4
Yanagi, M.5
Hiraoka, A.6
Karasuno, T.7
Takeuchi, M.8
Miyawaki, S.9
Ueda, R.10
Naoe, T.11
Ohno, R.12
-
76
-
-
41949111045
-
Acute promyelocytic leukemia: from highly fatal to highly curable
-
Wang, Z.Y. & Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 2505-2515.
-
(2008)
Blood
, vol.111
, pp. 2505-2515
-
-
Wang, Z.Y.1
Chen, Z.2
-
77
-
-
80051473507
-
The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis
-
Wang, H., Chen, X.Y., Wang, B.S., Rong, Z.X., Qi, H. & Chen, H.Z. (2011) The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis. Leukemia Research, 35, 1170-1177.
-
(2011)
Leukemia Research
, vol.35
, pp. 1170-1177
-
-
Wang, H.1
Chen, X.Y.2
Wang, B.S.3
Rong, Z.X.4
Qi, H.5
Chen, H.Z.6
-
78
-
-
84879164951
-
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia
-
Yanada, M., Tsuzuki, M., Fujita, H., Fujimaki, K., Fujisawa, S., Sunami, K., Taniwaki, M., Ohwada, A., Tsuboi, K., Maeda, A., Takeshita, A., Ohtake, S., Miyazaki, Y., Atsuta, Y., Kobayashi, Y., Naoe, T. & Emi, N.; Japan Adult Leukemia Study Group. (2013) Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia. Blood, 121, 3095-3102.
-
(2013)
Blood
, vol.121
, pp. 3095-3102
-
-
Yanada, M.1
Tsuzuki, M.2
Fujita, H.3
Fujimaki, K.4
Fujisawa, S.5
Sunami, K.6
Taniwaki, M.7
Ohwada, A.8
Tsuboi, K.9
Maeda, A.10
Takeshita, A.11
Ohtake, S.12
Miyazaki, Y.13
Atsuta, Y.14
Kobayashi, Y.15
Naoe, T.16
Emi, N.17
-
79
-
-
84918789988
-
Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia
-
Zhu, H.H. & Huang, X.J. (2014) Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia. New England Journal of Medicine, 371, 2239-2241.
-
(2014)
New England Journal of Medicine
, vol.371
, pp. 2239-2241
-
-
Zhu, H.H.1
Huang, X.J.2
-
80
-
-
84892940228
-
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenictrioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial
-
Zhu, H.H., Wu, D.P., Jin, J., Li, J.Y., Ma, J., Wang, J.X., Jiang, H., Chen, S.J. & Huang, X.J. (2013) Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenictrioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. Journal of Clinical Oncology, 31, 4215-4221.
-
(2013)
Journal of Clinical Oncology
, vol.31
, pp. 4215-4221
-
-
Zhu, H.H.1
Wu, D.P.2
Jin, J.3
Li, J.Y.4
Ma, J.5
Wang, J.X.6
Jiang, H.7
Chen, S.J.8
Huang, X.J.9
|